Endowed with a high potential to inhibit HER2high tumor growth, HER2bsFab also overcomes in vitro and in vivo limitations associated with the threshold of HER2 expression level on target cells and with NK cell polymorphism for eliciting efficient anti-tumor activity. Here, ERBB2 is linked to neoplasm.